These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
86-0629024
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
|
(IRS Employer Identification No.)
|
|
Large accelerated filer
|
x
|
|
Accelerated filer
|
o
|
|
Non-accelerated filer
|
o
|
|
Smaller reporting company
|
o
|
|
Class
|
|
Outstanding at August 4, 2015
|
|
Common Stock, $0.001 par value
|
|
211,091,149 shares
|
|
|
|
|
|
Page
|
|
|
|
|
|
PART I. FINANCIAL INFORMATION
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PART II. OTHER INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
CERTIFICATIONS
|
|
|
|
|
|
|
|
EXHIBITS
|
|
|
|
Item1.
|
Financial Statements
|
|
ASSETS
|
June 30,
2015 |
|
March 31,
2015 |
||||
|
Cash and cash equivalents
|
$
|
563,547
|
|
|
$
|
607,815
|
|
|
Short-term investments
|
969,003
|
|
|
1,351,054
|
|
||
|
Accounts receivable, net
|
277,033
|
|
|
273,937
|
|
||
|
Inventories
|
303,690
|
|
|
279,456
|
|
||
|
Prepaid expenses
|
33,927
|
|
|
34,717
|
|
||
|
Deferred tax assets
|
71,045
|
|
|
71,045
|
|
||
|
Assets held for sale
|
13,669
|
|
|
13,989
|
|
||
|
Other current assets
|
23,700
|
|
|
32,604
|
|
||
|
Total current assets
|
2,255,614
|
|
|
2,664,617
|
|
||
|
Property, plant and equipment, net
|
595,247
|
|
|
581,572
|
|
||
|
Long-term investments
|
898,024
|
|
|
383,326
|
|
||
|
Goodwill
|
571,660
|
|
|
571,271
|
|
||
|
Intangible assets, net
|
470,488
|
|
|
504,417
|
|
||
|
Other assets
|
65,952
|
|
|
75,510
|
|
||
|
Total assets
|
$
|
4,856,985
|
|
|
$
|
4,780,713
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
||||
|
Accounts payable
|
$
|
93,655
|
|
|
$
|
86,866
|
|
|
Accrued liabilities
|
111,124
|
|
|
100,978
|
|
||
|
Deferred income on shipments to distributors
|
167,529
|
|
|
166,128
|
|
||
|
Total current liabilities
|
372,308
|
|
|
353,972
|
|
||
|
Senior convertible debentures
|
1,169,583
|
|
|
1,174,036
|
|
||
|
Junior convertible debentures
|
192,162
|
|
|
190,870
|
|
||
|
Long-term line of credit
|
496,952
|
|
|
461,952
|
|
||
|
Long-term income tax payable
|
98,001
|
|
|
114,336
|
|
||
|
Long-term deferred tax liability
|
380,403
|
|
|
381,192
|
|
||
|
Other long-term liabilities
|
48,694
|
|
|
43,329
|
|
||
|
Stockholders' equity:
|
|
|
|
||||
|
Preferred stock, $0.001 par value; authorized 5,000,000 shares; no shares issued or outstanding
|
—
|
|
|
—
|
|
||
|
Common stock, $0.001 par value; authorized 450,000,000 shares; 218,789,994 shares issued and 202,407,537 shares outstanding at June 30, 2015; 218,789,994 shares issued and 202,080,306 shares outstanding at March 31, 2015
|
202
|
|
|
202
|
|
||
|
Additional paid-in capital
|
1,001,935
|
|
|
999,515
|
|
||
|
Common stock held in treasury: 16,382,457 shares at June 30, 2015; 16,709,688 shares at March 31, 2015
|
(505,960
|
)
|
|
(515,679
|
)
|
||
|
Accumulated other comprehensive (loss) income
|
(5,171
|
)
|
|
11,076
|
|
||
|
Retained earnings
|
1,607,876
|
|
|
1,549,540
|
|
||
|
Microchip Technology stockholders' equity
|
2,098,882
|
|
|
2,044,654
|
|
||
|
Noncontrolling interests
|
—
|
|
|
16,372
|
|
||
|
Total equity
|
2,098,882
|
|
|
2,061,026
|
|
||
|
Total liabilities and equity
|
$
|
4,856,985
|
|
|
$
|
4,780,713
|
|
|
|
Three Months Ended
|
||||||
|
|
June 30,
|
||||||
|
|
2015
|
|
2014
|
||||
|
Net sales
|
$
|
533,952
|
|
|
$
|
528,876
|
|
|
Cost of sales (1)
|
224,935
|
|
|
222,357
|
|
||
|
Gross profit
|
309,017
|
|
|
306,519
|
|
||
|
Operating expenses:
|
|
|
|
|
|
||
|
Research and development (1)
|
84,680
|
|
|
84,370
|
|
||
|
Selling, general and administrative (1)
|
66,849
|
|
|
69,255
|
|
||
|
Amortization of acquired intangible assets
|
34,612
|
|
|
36,644
|
|
||
|
Special charges, net
|
1,557
|
|
|
304
|
|
||
|
|
187,698
|
|
|
190,573
|
|
||
|
|
|
|
|
||||
|
Operating income
|
121,319
|
|
|
115,946
|
|
||
|
Losses on equity method investments
|
(177
|
)
|
|
(32
|
)
|
||
|
Other income (expense):
|
|
|
|
||||
|
Interest income
|
5,528
|
|
|
4,742
|
|
||
|
Interest expense
|
(24,052
|
)
|
|
(13,678
|
)
|
||
|
Other income, net
|
16,947
|
|
|
13
|
|
||
|
Income before income taxes
|
119,565
|
|
|
106,991
|
|
||
|
Income tax (benefit) provision
|
(10,895
|
)
|
|
17,082
|
|
||
|
Net income
|
130,460
|
|
|
89,909
|
|
||
|
Less: Net loss attributable to noncontrolling interests
|
207
|
|
|
—
|
|
||
|
Net income attributable to Microchip Technology
|
$
|
130,667
|
|
|
$
|
89,909
|
|
|
Basic net income per common share attributable to Microchip Technology stockholders
|
$
|
0.65
|
|
|
$
|
0.45
|
|
|
Diluted net income per common share attributable to Microchip Technology stockholders
|
$
|
0.60
|
|
|
$
|
0.40
|
|
|
Dividends declared per common share
|
$
|
0.3575
|
|
|
$
|
0.3555
|
|
|
Basic common shares outstanding
|
202,232
|
|
|
200,187
|
|
||
|
Diluted common shares outstanding
|
216,767
|
|
|
224,527
|
|
||
|
(1) Includes share-based compensation expense as follows:
|
|
|
|
||||
|
Cost of sales
|
$
|
1,657
|
|
|
$
|
2,055
|
|
|
Research and development
|
7,098
|
|
|
6,309
|
|
||
|
Selling, general and administrative
|
5,357
|
|
|
4,957
|
|
||
|
|
Three Months Ended
|
||||||
|
|
June 30,
|
||||||
|
|
2015
|
|
2014
|
||||
|
Net income
|
$
|
130,460
|
|
|
$
|
89,909
|
|
|
Less: Net loss attributable to noncontrolling interests
|
207
|
|
|
—
|
|
||
|
Net income attributable to Microchip Technology
|
130,667
|
|
|
89,909
|
|
||
|
|
|
|
|
||||
|
Components of other comprehensive (loss) income:
|
|
|
|
||||
|
Available-for-sale securities:
|
|
|
|
||||
|
Unrealized holding (losses) gains, net of tax effect of $0 and $12, respectively
|
(2,012
|
)
|
|
3,060
|
|
||
|
Reclassification of realized transactions, net of tax effect of $0 and $12, respectively
|
(13,959
|
)
|
|
(22
|
)
|
||
|
Other comprehensive (loss) income, net of taxes
|
(15,971
|
)
|
|
3,038
|
|
||
|
Less: Other comprehensive (income) loss attributable to noncontrolling interests
|
—
|
|
|
—
|
|
||
|
Other comprehensive (loss) income attributable to Microchip Technology
|
(15,971
|
)
|
|
3,038
|
|
||
|
|
|
|
|
||||
|
Comprehensive income
|
114,489
|
|
|
92,947
|
|
||
|
Less: Comprehensive loss attributable to noncontrolling interests
|
207
|
|
|
—
|
|
||
|
Comprehensive income attributable to Microchip Technology
|
$
|
114,696
|
|
|
$
|
92,947
|
|
|
|
Three Months Ended
|
||||||
|
|
June 30,
|
||||||
|
|
2015
|
|
2014
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net income
|
$
|
130,460
|
|
|
$
|
89,909
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
60,375
|
|
|
60,988
|
|
||
|
Deferred income taxes
|
(17,509
|
)
|
|
(2,319
|
)
|
||
|
Share-based compensation expense related to equity incentive plans
|
14,112
|
|
|
13,321
|
|
||
|
Excess tax benefit from share-based compensation
|
(263
|
)
|
|
—
|
|
||
|
Amortization of debt discount on convertible debentures
|
11,772
|
|
|
2,365
|
|
||
|
Amortization of debt issuance costs
|
958
|
|
|
544
|
|
||
|
Losses on equity method investments
|
177
|
|
|
32
|
|
||
|
Gain on sale of assets
|
(560
|
)
|
|
—
|
|
||
|
Impairment of intangible assets
|
—
|
|
|
406
|
|
||
|
Realized gain on available-for-sale investment
|
(13,959
|
)
|
|
—
|
|
||
|
Realized gain on equity method investment
|
(2,225
|
)
|
|
—
|
|
||
|
Amortization of premium on available-for-sale investments
|
2,396
|
|
|
2,589
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Increase in accounts receivable
|
(3,096
|
)
|
|
(37,247
|
)
|
||
|
(Increase) decrease in inventories
|
(23,893
|
)
|
|
24,991
|
|
||
|
Increase (decrease) in deferred income on shipments to distributors
|
1,401
|
|
|
(1,215
|
)
|
||
|
Increase (decrease) in accounts payable and accrued liabilities
|
16,157
|
|
|
(4,415
|
)
|
||
|
Change in other assets and liabilities
|
5,225
|
|
|
15,839
|
|
||
|
Net cash provided by operating activities
|
181,528
|
|
|
165,788
|
|
||
|
Cash flows from investing activities:
|
|
|
|
|
|
||
|
Purchases of available-for-sale investments
|
(570,501
|
)
|
|
(172,506
|
)
|
||
|
Sales and maturities of available-for-sale investments
|
433,446
|
|
|
321,203
|
|
||
|
Sale of equity method investment
|
2,667
|
|
|
—
|
|
||
|
Purchase of additional controlling interest in ISSC
|
(18,051
|
)
|
|
—
|
|
||
|
Acquisition of Supertex, net of cash acquired
|
—
|
|
|
(375,365
|
)
|
||
|
Investments in other assets
|
(1,766
|
)
|
|
(1,123
|
)
|
||
|
Proceeds from sale of assets
|
627
|
|
|
—
|
|
||
|
Capital expenditures
|
(33,611
|
)
|
|
(44,637
|
)
|
||
|
Net cash used in investing activities
|
(187,189
|
)
|
|
(272,428
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
|
|
||
|
Repayments of revolving loan under credit facility
|
(110,000
|
)
|
|
(170,000
|
)
|
||
|
Proceeds from borrowings on revolving loan under credit facility
|
145,000
|
|
|
504,375
|
|
||
|
Repayments of long-term borrowings
|
—
|
|
|
(4,375
|
)
|
||
|
Deferred financing costs
|
(406
|
)
|
|
—
|
|
||
|
Payment of cash dividends
|
(72,331
|
)
|
|
(71,202
|
)
|
||
|
Proceeds from sale of common stock
|
3,497
|
|
|
4,125
|
|
||
|
Tax payments related to shares withheld for vested restricted stock units
|
(4,464
|
)
|
|
(4,968
|
)
|
||
|
Capital lease payments
|
(166
|
)
|
|
(148
|
)
|
||
|
Excess tax benefit from share-based compensation
|
263
|
|
|
—
|
|
||
|
Net cash (used in) provided by financing activities
|
(38,607
|
)
|
|
257,807
|
|
||
|
Net (decrease) increase in cash and cash equivalents
|
(44,268
|
)
|
|
151,167
|
|
||
|
Cash and cash equivalents at beginning of period
|
607,815
|
|
|
466,603
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
563,547
|
|
|
$
|
617,770
|
|
|
(1)
|
Basis of Presentation
|
|
(2)
|
Business Acquisitions
|
|
Assets acquired
|
Previously Reported March 31, 2015
|
|
Adjustments
|
|
June 30, 2015
|
||||||
|
Cash and cash equivalents
|
$
|
15,120
|
|
|
$
|
—
|
|
|
$
|
15,120
|
|
|
Short-term investments
|
27,063
|
|
|
—
|
|
|
27,063
|
|
|||
|
Accounts receivable, net
|
8,792
|
|
|
—
|
|
|
8,792
|
|
|||
|
Inventories
|
16,542
|
|
|
—
|
|
|
16,542
|
|
|||
|
Prepaid expenses and other current assets
|
2,501
|
|
|
—
|
|
|
2,501
|
|
|||
|
Property, plant and equipment, net
|
2,637
|
|
|
—
|
|
|
2,637
|
|
|||
|
Goodwill
|
154,399
|
|
|
389
|
|
|
154,788
|
|
|||
|
Purchased intangible assets
|
147,800
|
|
|
—
|
|
|
147,800
|
|
|||
|
Other assets
|
1,370
|
|
|
—
|
|
|
1,370
|
|
|||
|
Total assets acquired
|
376,224
|
|
|
389
|
|
|
376,613
|
|
|||
|
|
|
|
|
|
|
||||||
|
Liabilities assumed
|
|
|
|
|
|
||||||
|
Accounts payable
|
(9,860
|
)
|
|
—
|
|
|
(9,860
|
)
|
|||
|
Other current liabilities
|
(16,535
|
)
|
|
—
|
|
|
(16,535
|
)
|
|||
|
Long-term income tax payable
|
(4,402
|
)
|
|
(389
|
)
|
|
(4,791
|
)
|
|||
|
Deferred tax liability
|
(25,126
|
)
|
|
—
|
|
|
(25,126
|
)
|
|||
|
Other long-term liabilities
|
(245
|
)
|
|
—
|
|
|
(245
|
)
|
|||
|
Total liabilities assumed
|
(56,168
|
)
|
|
(389
|
)
|
|
(56,557
|
)
|
|||
|
Net assets acquired including noncontrolling interest
|
320,056
|
|
|
—
|
|
|
320,056
|
|
|||
|
Less: noncontrolling interest
|
(52,467
|
)
|
|
—
|
|
|
(52,467
|
)
|
|||
|
Net assets acquired
|
$
|
267,589
|
|
|
$
|
—
|
|
|
$
|
267,589
|
|
|
Purchased Intangible Assets
|
Useful Life
|
|
July 17, 2014
|
||
|
|
(in years)
|
|
(in thousands)
|
||
|
Core/developed technology
|
10
|
|
$
|
68,900
|
|
|
In-process technology
|
10
|
|
27,200
|
|
|
|
Customer-related
|
3
|
|
51,100
|
|
|
|
Backlog
|
1
|
|
600
|
|
|
|
|
|
|
$
|
147,800
|
|
|
Assets acquired
|
March 31, 2015
|
||
|
Cash and cash equivalents
|
$
|
14,790
|
|
|
Short-term investments
|
140,984
|
|
|
|
Accounts receivable, net
|
7,047
|
|
|
|
Inventories
|
27,630
|
|
|
|
Prepaid expenses
|
1,493
|
|
|
|
Deferred tax assets
|
2,456
|
|
|
|
Other current assets
|
12,625
|
|
|
|
Property, plant and equipment, net
|
15,679
|
|
|
|
Goodwill
|
143,160
|
|
|
|
Purchased intangible assets
|
89,600
|
|
|
|
Other assets
|
325
|
|
|
|
Total assets acquired
|
455,789
|
|
|
|
|
|
||
|
Liabilities assumed
|
|
||
|
Accounts payable
|
(8,481
|
)
|
|
|
Accrued liabilities
|
(19,224
|
)
|
|
|
Long-term income tax payable
|
(3,796
|
)
|
|
|
Deferred tax liability
|
(32,511
|
)
|
|
|
Total liabilities assumed
|
(64,012
|
)
|
|
|
Net assets acquired
|
$
|
391,777
|
|
|
Purchased Intangible Assets
|
Useful Life
|
|
April 1, 2014
|
||
|
|
(in years)
|
|
(in thousands)
|
||
|
Core/developed technology
|
10
|
|
$
|
68,900
|
|
|
In-process technology
|
10
|
|
1,900
|
|
|
|
Customer-related
|
2
|
|
17,700
|
|
|
|
Backlog
|
1
|
|
1,100
|
|
|
|
|
|
|
$
|
89,600
|
|
|
(3)
|
Recently Issued Accounting Pronouncements
|
|
(4)
|
Special Charges
|
|
(5)
|
Segment Information
|
|
|
Three Months Ended
|
||||||
|
|
June 30, 2015
|
||||||
|
|
Net Sales
|
|
Gross Profit
|
||||
|
Semiconductor products
|
$
|
510,689
|
|
|
$
|
285,754
|
|
|
Technology licensing
|
23,263
|
|
|
23,263
|
|
||
|
|
$
|
533,952
|
|
|
$
|
309,017
|
|
|
|
Three Months Ended
|
||||||
|
|
June 30, 2014
|
||||||
|
|
Net Sales
|
|
Gross Profit
|
||||
|
Semiconductor products
|
$
|
508,439
|
|
|
$
|
286,082
|
|
|
Technology licensing
|
20,437
|
|
|
20,437
|
|
||
|
|
$
|
528,876
|
|
|
$
|
306,519
|
|
|
(6)
|
Investments
|
|
|
Available-for-sale Securities
|
||||||||||||||
|
|
Adjusted
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair Value
|
||||||||
|
Government agency bonds
|
$
|
799,662
|
|
|
$
|
494
|
|
|
$
|
(1,150
|
)
|
|
$
|
799,006
|
|
|
Municipal bonds
|
41,142
|
|
|
9
|
|
|
(765
|
)
|
|
40,386
|
|
||||
|
Auction rate securities
|
9,825
|
|
|
—
|
|
|
—
|
|
|
9,825
|
|
||||
|
Corporate bonds and debt
|
1,017,832
|
|
|
1,149
|
|
|
(1,171
|
)
|
|
1,017,810
|
|
||||
|
|
$
|
1,868,461
|
|
|
$
|
1,652
|
|
|
$
|
(3,086
|
)
|
|
$
|
1,867,027
|
|
|
|
Available-for-sale Securities
|
||||||||||||||
|
|
Adjusted
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair Value
|
||||||||
|
Government agency bonds
|
$
|
741,780
|
|
|
$
|
676
|
|
|
$
|
(200
|
)
|
|
$
|
742,256
|
|
|
Municipal bonds
|
41,552
|
|
|
155
|
|
|
(9
|
)
|
|
41,698
|
|
||||
|
Auction rate securities
|
9,825
|
|
|
—
|
|
|
—
|
|
|
9,825
|
|
||||
|
Time deposits
(1)
|
506
|
|
|
—
|
|
|
—
|
|
|
506
|
|
||||
|
Corporate bonds and debt
|
924,818
|
|
|
2,376
|
|
|
(265
|
)
|
|
926,929
|
|
||||
|
Marketable equity securities
|
1,362
|
|
|
11,804
|
|
|
—
|
|
|
13,166
|
|
||||
|
|
$
|
1,719,843
|
|
|
$
|
15,011
|
|
|
$
|
(474
|
)
|
|
$
|
1,734,380
|
|
|
|
June 30, 2015
|
||||||||||||||||||||||
|
|
Less than 12 Months
|
|
12 Months or Greater
|
|
Total
|
||||||||||||||||||
|
|
Fair Value
|
|
Unrealized Loss
|
|
Fair Value
|
|
Unrealized Loss
|
|
Fair Value
|
|
Unrealized Loss
|
||||||||||||
|
Government agency bonds
|
$
|
442,847
|
|
|
$
|
(1,061
|
)
|
|
$
|
14,911
|
|
|
$
|
(89
|
)
|
|
$
|
457,758
|
|
|
$
|
(1,150
|
)
|
|
Municipal bonds
|
37,104
|
|
|
(765
|
)
|
|
—
|
|
|
—
|
|
|
37,104
|
|
|
(765
|
)
|
||||||
|
Corporate bonds and debt
|
424,510
|
|
|
(1,088
|
)
|
|
28,059
|
|
|
(83
|
)
|
|
452,569
|
|
|
(1,171
|
)
|
||||||
|
|
$
|
904,461
|
|
|
$
|
(2,914
|
)
|
|
$
|
42,970
|
|
|
$
|
(172
|
)
|
|
$
|
947,431
|
|
|
$
|
(3,086
|
)
|
|
|
March 31, 2015
|
||||||||||||||||||||||
|
|
Less than 12 Months
|
|
12 Months or Greater
|
|
Total
|
||||||||||||||||||
|
|
Fair Value
|
|
Unrealized Loss
|
|
Fair Value
|
|
Unrealized Loss
|
|
Fair Value
|
|
Unrealized Loss
|
||||||||||||
|
Government agency bonds
|
$
|
162,948
|
|
|
$
|
(142
|
)
|
|
$
|
29,942
|
|
|
$
|
(58
|
)
|
|
$
|
192,890
|
|
|
$
|
(200
|
)
|
|
Municipal bonds
|
13,318
|
|
|
(9
|
)
|
|
—
|
|
|
—
|
|
|
13,318
|
|
|
(9
|
)
|
||||||
|
Corporate bonds and debt
|
163,095
|
|
|
(219
|
)
|
|
19,021
|
|
|
(46
|
)
|
|
182,116
|
|
|
(265
|
)
|
||||||
|
|
$
|
339,361
|
|
|
$
|
(370
|
)
|
|
$
|
48,963
|
|
|
$
|
(104
|
)
|
|
$
|
388,324
|
|
|
$
|
(474
|
)
|
|
|
Adjusted
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair Value
|
||||||||
|
Available-for-sale
|
|
|
|
|
|
|
|
||||||||
|
Due in one year or less
|
$
|
269,962
|
|
|
$
|
295
|
|
|
$
|
(78
|
)
|
|
$
|
270,179
|
|
|
Due after one year and through five years
|
1,485,199
|
|
|
1,357
|
|
|
(2,190
|
)
|
|
1,484,366
|
|
||||
|
Due after five years and through ten years
|
97,285
|
|
|
—
|
|
|
(818
|
)
|
|
96,467
|
|
||||
|
Due after ten years
|
9,825
|
|
|
—
|
|
|
—
|
|
|
9,825
|
|
||||
|
|
$
|
1,862,271
|
|
|
$
|
1,652
|
|
|
$
|
(3,086
|
)
|
|
$
|
1,860,837
|
|
|
(7)
|
Fair Value Measurements
|
|
Level 1-
|
Observable inputs such as quoted prices in active markets;
|
|
Level 2-
|
Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
|
|
Level 3-
|
Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
|
|
|
Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
Total
Balance
|
||||||||
|
Assets
|
|
|
|
|
|
|
|
||||||||
|
Cash and cash equivalents:
|
|
|
|
|
|
|
|
||||||||
|
Money market mutual funds
|
$
|
217,606
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
217,606
|
|
|
Deposit accounts
|
—
|
|
|
345,941
|
|
|
—
|
|
|
345,941
|
|
||||
|
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
|
Corporate bonds and debt
|
—
|
|
|
611,880
|
|
|
—
|
|
|
611,880
|
|
||||
|
Government agency bonds
|
—
|
|
|
351,247
|
|
|
—
|
|
|
351,247
|
|
||||
|
Municipal bonds
|
—
|
|
|
5,876
|
|
|
—
|
|
|
5,876
|
|
||||
|
Long-term investments:
|
|
|
|
|
|
|
|
||||||||
|
Corporate bonds and debt
|
—
|
|
|
399,740
|
|
|
6,190
|
|
|
405,930
|
|
||||
|
Government agency bonds
|
—
|
|
|
447,760
|
|
|
—
|
|
|
447,760
|
|
||||
|
Municipal bonds
|
—
|
|
|
34,509
|
|
|
—
|
|
|
34,509
|
|
||||
|
Auction rate securities
|
—
|
|
|
—
|
|
|
9,825
|
|
|
9,825
|
|
||||
|
Total assets measured at fair value
|
$
|
217,606
|
|
|
$
|
2,196,953
|
|
|
$
|
16,015
|
|
|
$
|
2,430,574
|
|
|
Liabilities
|
|
|
|
|
|
|
|
||||||||
|
Derivative liabilities
|
$
|
—
|
|
|
$
|
6,042
|
|
|
$
|
—
|
|
|
$
|
6,042
|
|
|
Total liabilities measured at fair value
|
$
|
—
|
|
|
$
|
6,042
|
|
|
$
|
—
|
|
|
$
|
6,042
|
|
|
|
Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
Total
Balance
|
||||||||
|
Assets
|
|
|
|
|
|
|
|
||||||||
|
Cash and cash equivalents:
|
|
|
|
|
|
|
|
||||||||
|
Money market mutual funds
|
$
|
279,833
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
279,833
|
|
|
Deposit accounts
|
—
|
|
|
327,982
|
|
|
—
|
|
|
327,982
|
|
||||
|
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
|
Marketable equity securities
|
13,166
|
|
|
—
|
|
|
—
|
|
|
13,166
|
|
||||
|
Corporate bonds and debt
|
—
|
|
|
756,664
|
|
|
—
|
|
|
756,664
|
|
||||
|
Time deposits
(1)
|
—
|
|
|
506
|
|
|
—
|
|
|
506
|
|
||||
|
Government agency bonds
|
—
|
|
|
549,737
|
|
|
—
|
|
|
549,737
|
|
||||
|
Municipal bonds
|
—
|
|
|
30,981
|
|
|
—
|
|
|
30,981
|
|
||||
|
Long-term investments:
|
|
|
|
|
|
|
|
||||||||
|
Corporate bonds and debt
|
—
|
|
|
164,075
|
|
|
6,190
|
|
|
170,265
|
|
||||
|
Government agency bonds
|
—
|
|
|
192,519
|
|
|
—
|
|
|
192,519
|
|
||||
|
Municipal bonds
|
—
|
|
|
10,717
|
|
|
—
|
|
|
10,717
|
|
||||
|
Auction rate securities
|
—
|
|
|
—
|
|
|
9,825
|
|
|
9,825
|
|
||||
|
Derivative assets
|
—
|
|
|
8,928
|
|
|
—
|
|
|
8,928
|
|
||||
|
Total assets measured at fair value
|
$
|
292,999
|
|
|
$
|
2,042,109
|
|
|
$
|
16,015
|
|
|
$
|
2,351,123
|
|
|
(8)
|
Fair Value of Financial Instruments
|
|
(9)
|
Accounts Receivable
|
|
|
June 30, 2015
|
|
March 31, 2015
|
||||
|
Trade accounts receivable
|
$
|
276,087
|
|
|
$
|
269,844
|
|
|
Other
|
3,535
|
|
|
6,714
|
|
||
|
|
279,622
|
|
|
276,558
|
|
||
|
Less allowance for doubtful accounts
|
2,589
|
|
|
2,621
|
|
||
|
|
$
|
277,033
|
|
|
$
|
273,937
|
|
|
(10)
|
Inventories
|
|
|
June 30, 2015
|
|
March 31, 2015
|
||||
|
Raw materials
|
$
|
14,066
|
|
|
$
|
13,263
|
|
|
Work in process
|
216,390
|
|
|
197,565
|
|
||
|
Finished goods
|
73,234
|
|
|
68,628
|
|
||
|
|
$
|
303,690
|
|
|
$
|
279,456
|
|
|
(11)
|
Assets Held for Sale
|
|
(12)
|
Property, Plant and Equipment
|
|
|
June 30, 2015
|
|
March 31, 2015
|
||||
|
Land
|
$
|
55,624
|
|
|
$
|
55,624
|
|
|
Building and building improvements
|
437,751
|
|
|
434,403
|
|
||
|
Machinery and equipment
|
1,598,481
|
|
|
1,576,074
|
|
||
|
Projects in process
|
86,093
|
|
|
76,315
|
|
||
|
|
2,177,949
|
|
|
2,142,416
|
|
||
|
Less accumulated depreciation and amortization
|
1,582,702
|
|
|
1,560,844
|
|
||
|
|
$
|
595,247
|
|
|
$
|
581,572
|
|
|
(13)
|
Noncontrolling Interests
|
|
|
Noncontrolling Interests
|
||
|
Balance at March 31, 2015
|
$
|
16,372
|
|
|
Net loss attributable to noncontrolling interests
|
(207
|
)
|
|
|
Purchase of additional interests
|
(16,165
|
)
|
|
|
Balance at June 30, 2015
|
$
|
—
|
|
|
|
Three Months Ended
|
||
|
|
June 30, 2015
|
||
|
Net income attributable to Microchip Technology stockholders
|
$
|
130,667
|
|
|
Decrease in paid-in capital for purchase of additional interests
|
(1,610
|
)
|
|
|
Transfers from noncontrolling interest
|
(1,610
|
)
|
|
|
Change from net income attributable to Microchip Technology stockholders and transfers from noncontrolling interest
|
$
|
129,057
|
|
|
(14)
|
Income Taxes
|
|
(15)
|
1.625% Senior Subordinated Convertible Debentures
|
|
(16)
|
2.125% Junior Subordinated Convertible Debentures
|
|
(17)
|
Credit Facility
|
|
(18)
|
Contingencies
|
|
(19)
|
Derivative Instruments
|
|
|
|
June 30, 2015
|
|
March 31, 2015
|
||||||||||||
|
Derivatives designated as hedging instruments
|
|
Other long-term liabilities
|
|
Other assets
|
|
Other long-term liabilities
|
|
Other assets
|
||||||||
|
Interest rate contracts
|
|
$
|
6,042
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
8,928
|
|
|
Income Statement Classification
|
|
Gain (Loss) on Senior Subordinated Convertible Debentures
|
|
Gain (Loss) on Interest Rate Swap
|
||||
|
Other Income (Expense)
|
|
$
|
14,931
|
|
|
$
|
(14,971
|
)
|
|
(20)
|
Comprehensive Income (Loss)
|
|
|
Unrealized
holding gains (losses)
available-for-sale securities
|
|
Minimum
pension
liability
|
|
Foreign
Currency
|
|
Total
|
||||||||
|
Balance at March 31, 2015
|
$
|
14,537
|
|
|
$
|
13
|
|
|
$
|
(3,474
|
)
|
|
$
|
11,076
|
|
|
Other comprehensive (loss) income before reclassifications
|
(2,012
|
)
|
|
—
|
|
|
—
|
|
|
(2,012
|
)
|
||||
|
Amounts reclassified from accumulated other comprehensive (loss) income
|
(13,959
|
)
|
|
—
|
|
|
—
|
|
|
(13,959
|
)
|
||||
|
Net other comprehensive (loss) income
|
(15,971
|
)
|
|
—
|
|
|
—
|
|
|
(15,971
|
)
|
||||
|
Purchase of shares from noncontrolling interest
|
—
|
|
|
—
|
|
|
(276
|
)
|
|
(276
|
)
|
||||
|
Balance at June 30, 2015
|
$
|
(1,434
|
)
|
|
$
|
13
|
|
|
$
|
(3,750
|
)
|
|
$
|
(5,171
|
)
|
|
|
|
Three Months Ended
|
|
|
||||||
|
|
|
June 30,
|
|
|
||||||
|
Description of AOCI Component
|
|
2015
|
|
2014
|
|
Related Statement
of Income Line
|
||||
|
Unrealized gains on available-for-sale securities
|
|
$
|
13,959
|
|
|
$
|
34
|
|
|
Other income
|
|
Taxes
|
|
—
|
|
|
(12
|
)
|
|
Provision for income taxes
|
||
|
Reclassification of realized transactions, net of taxes
|
|
$
|
13,959
|
|
|
$
|
22
|
|
|
Net income
|
|
(21)
|
Share-Based Compensation
|
|
|
Three Months Ended
|
|
||||||
|
|
June 30,
|
|
||||||
|
|
2015
|
|
2014
|
|
||||
|
Cost of sales
|
$
|
1,657
|
|
(1)
|
$
|
2,055
|
|
(1)
|
|
Research and development
|
7,098
|
|
|
6,309
|
|
|
||
|
Selling, general and administrative
|
5,357
|
|
|
4,957
|
|
|
||
|
Pre-tax effect of share-based compensation
|
14,112
|
|
|
13,321
|
|
|
||
|
Income tax benefit
|
3,532
|
|
|
1,420
|
|
|
||
|
Net income effect of share-based compensation
|
$
|
10,580
|
|
|
$
|
11,901
|
|
|
|
(22)
|
Net Income Per Common Share Attributable to Microchip Technology Stockholders
|
|
|
Three Months Ended
|
||||||
|
|
June 30,
|
||||||
|
|
2015
|
|
2014
|
||||
|
Net income attributable to Microchip Technology
|
$
|
130,667
|
|
|
$
|
89,909
|
|
|
Weighted average common shares outstanding
|
202,232
|
|
|
200,187
|
|
||
|
Dilutive effect of stock options and RSUs
|
3,392
|
|
|
3,792
|
|
||
|
Dilutive effect of 2037 junior subordinated convertible debentures
|
11,143
|
|
|
20,548
|
|
||
|
Weighted average common and potential common shares outstanding
|
216,767
|
|
|
224,527
|
|
||
|
Basic net income per common share attributable to Microchip Technology stockholders
|
$
|
0.65
|
|
|
$
|
0.45
|
|
|
Diluted net income per common share attributable to Microchip Technology stockholders
|
$
|
0.60
|
|
|
$
|
0.40
|
|
|
(23)
|
Dividends
|
|
(24)
|
Subsequent Event
|
|
•
|
The effects that adverse global economic conditions and fluctuations in the global credit and equity markets may have on our financial condition and results of operations;
|
|
•
|
The effects and amount of competitive pricing pressure on our product lines;
|
|
•
|
Our ability to moderate future average selling price declines;
|
|
•
|
The effect of product mix, capacity utilization, yields, fixed cost absorption, competition and economic conditions on gross margin;
|
|
•
|
The amount of, and changes in, demand for our products and those of our customers;
|
|
•
|
Our expectation that in the future we will acquire additional businesses that we believe will complement our existing businesses;
|
|
•
|
Our expectation that in the future we will enter into joint development agreements or other business or strategic relationships with other companies;
|
|
•
|
The level of orders that will be received and shipped within a quarter;
|
|
•
|
Our expectation that our inventory levels will be up between 2 and 17 days in the September 2015 quarter compared to the June 2015 quarter and that it will allow us to maintain competitive lead times and provide strong delivery performance to our customers;
|
|
•
|
The effect that distributor and customer inventory holding patterns will have on us;
|
|
•
|
Our belief that customers recognize our products and brand name and use distributors as an effective supply channel;
|
|
•
|
Anticipating increased customer requirements to meet voluntary criteria related to the reduction or elimination of substances in our products;
|
|
•
|
Our belief that deferred cost of sales are recorded at their approximate carrying value and will have low risk of material impairment;
|
|
•
|
Our belief that our direct sales personnel combined with our distributors provide an effective means of reaching our customer base;
|
|
•
|
Our ability to increase the proprietary portion of our analog and interface product lines and the effect of such an increase;
|
|
•
|
Our belief that our processes afford us both cost-effective designs in existing and derivative products and greater functionality in new product designs;
|
|
•
|
The impact of any supply disruption we may experience;
|
|
•
|
Our ability to effectively utilize our facilities at appropriate capacity levels and anticipated costs;
|
|
•
|
That we adjust capacity utilization to respond to actual and anticipated business and industry-related conditions;
|
|
•
|
That our existing facilities will provide sufficient capacity to respond to increases in demand with modest incremental capital expenditures;
|
|
•
|
That manufacturing costs will be reduced by transition to advanced process technologies;
|
|
•
|
Our ability to maintain manufacturing yields;
|
|
•
|
Continuing our investments in new and enhanced products;
|
|
•
|
The cost effectiveness of using our own assembly and test operations;
|
|
•
|
Our anticipated level of capital expenditures;
|
|
•
|
Our intent to repurchase the approximate number of shares we will issue in connection with our acquisition of Micrel;
|
|
•
|
Continuation and amount of quarterly cash dividends;
|
|
•
|
The sufficiency of our existing sources of liquidity to finance anticipated capital expenditures and otherwise meet our anticipated cash requirements, and the effects that our contractual obligations are expected to have on them;
|
|
•
|
The impact of seasonality on our business;
|
|
•
|
The accuracy of our estimates used in valuing employee equity awards;
|
|
•
|
That the resolution of legal actions will not have a material effect on our business, and the accuracy of our assessment of the probability of loss and range of potential loss;
|
|
•
|
The recoverability of our deferred tax assets;
|
|
•
|
The adequacy of our tax reserves to offset any potential tax liabilities, having the appropriate support for our income tax positions and the accuracy of our estimated tax rate;
|
|
•
|
Our belief that the expiration of any tax holidays will not have a material impact on our overall tax expense or effective tax rate;
|
|
•
|
Our belief that the estimates used in preparing our consolidated financial statements are reasonable;
|
|
•
|
Our belief that recently issued accounting pronouncements listed in this document will not have a significant impact on our consolidated financial statements;
|
|
•
|
Our actions to vigorously and aggressively defend and protect our intellectual property on a worldwide basis;
|
|
•
|
Our ability to obtain patents and intellectual property licenses and minimize the effects of litigation;
|
|
•
|
The level of risk we are exposed to for product liability claims or indemnification claims;
|
|
•
|
The effect of fluctuations in market interest rates on our income and/or cash flows;
|
|
•
|
The effect of fluctuations in currency rates;
|
|
•
|
Our belief that any of the unrealized losses in our investment portfolio represent an other-than-temporary impairment and that recovery is not anticipated to occur in the next year;
|
|
•
|
That our offshore earnings are considered to be permanently reinvested offshore and that we could determine to repatriate some of our offshore earnings in future periods to fund stockholder dividends, share repurchases, acquisitions or other corporate activities;
|
|
•
|
That a significant portion of our future cash generation will be in our foreign subsidiaries;
|
|
•
|
Our intention to indefinitely reinvest undistributed earnings of certain non-US subsidiaries in those subsidiaries;
|
|
•
|
Our intent to maintain a high-quality investment portfolio that preserves principal, meets liquidity needs, avoids inappropriate concentrations and delivers an appropriate yield; and
|
|
•
|
Our ability to collect accounts receivable.
|
|
|
Three Months Ended
|
||||
|
|
June 30,
|
||||
|
|
2015
|
|
2014
|
||
|
Net sales
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of sales
|
42.1
|
|
|
42.0
|
|
|
Gross profit
|
57.9
|
|
|
58.0
|
|
|
Research and development
|
15.9
|
|
|
16.0
|
|
|
Selling, general and administrative
|
12.5
|
|
|
13.1
|
|
|
Amortization of acquired intangible assets
|
6.5
|
|
|
6.9
|
|
|
Special charges, net
|
0.3
|
|
|
0.1
|
|
|
Operating income
|
22.7
|
%
|
|
21.9
|
%
|
|
•
|
our acquisition of a controlling interest in ISSC on July 17, 2014;
|
|
•
|
global economic conditions in the markets we serve;
|
|
•
|
semiconductor industry conditions;
|
|
•
|
our new product offerings that have increased our served available market;
|
|
•
|
customers' increasing needs for the flexibility offered by our programmable solutions;
|
|
•
|
inventory holding patterns of our customers;
|
|
•
|
increasing semiconductor content in our customers' products; and
|
|
•
|
continued market share gains in the segments of the markets we address.
|
|
|
Three Months Ended
|
||||||||||||
|
|
June 30,
|
||||||||||||
|
|
(unaudited)
|
||||||||||||
|
|
2015
|
|
%
|
|
2014
|
|
%
|
||||||
|
Microcontrollers
|
$
|
348,170
|
|
|
65.2
|
|
|
$
|
343,761
|
|
|
65.0
|
|
|
Analog, interface and mixed signal products
|
127,055
|
|
|
23.8
|
|
|
125,357
|
|
|
23.7
|
|
||
|
Memory products
|
31,773
|
|
|
5.9
|
|
|
33,379
|
|
|
6.3
|
|
||
|
Technology licensing
|
23,263
|
|
|
4.4
|
|
|
20,437
|
|
|
3.9
|
|
||
|
Other
|
3,691
|
|
|
0.7
|
|
|
5,942
|
|
|
1.1
|
|
||
|
Total sales
|
$
|
533,952
|
|
|
100.0
|
%
|
|
$
|
528,876
|
|
|
100.0
|
%
|
|
|
Three Months Ended
|
||||||||||||
|
|
June 30,
|
||||||||||||
|
|
(unaudited)
|
||||||||||||
|
|
2015
|
|
%
|
|
2014
|
|
%
|
||||||
|
Americas
|
$
|
104,544
|
|
|
19.6
|
|
|
$
|
102,204
|
|
|
19.3
|
|
|
Europe
|
114,678
|
|
|
21.5
|
|
|
109,398
|
|
|
20.7
|
|
||
|
Asia
|
314,730
|
|
|
58.9
|
|
|
317,274
|
|
|
60.0
|
|
||
|
Total sales
|
$
|
533,952
|
|
|
100.0
|
%
|
|
$
|
528,876
|
|
|
100.0
|
%
|
|
•
|
for the three-month period ended June 30, 2015, inventory write-downs being higher than the gross margin impact of sales of inventory that was previously written down;
|
|
•
|
for the three-month period ended June 30, 2014, inventory write-downs being lower than the gross margin impact of sales of inventory that was previously written down;
|
|
•
|
charges of approximately $7.8 million in the three-month period ended June 30, 2014, related to the recognition of acquired inventory at fair value as a result of our acquisitions which increased the value of our acquired inventory and reduced our gross margins; and
|
|
•
|
fluctuations in our product mix of microcontrollers, analog, interface and mixed signal products, memory products and technology licensing.
|
|
•
|
continual cost reductions in wafer fabrication and assembly and test manufacturing, such as new manufacturing technologies and more efficient manufacturing techniques; and
|
|
•
|
lower depreciation as a percentage of cost of sales.
|
|
|
Financial instruments maturing during the fiscal year ended March 31,
|
||||||||||||||||||||||
|
|
2016
|
|
2017
|
|
2018
|
|
2019
|
|
2020
|
|
Thereafter
|
||||||||||||
|
Available-for-sale securities
|
$
|
181,598
|
|
|
$
|
547,412
|
|
|
$
|
504,566
|
|
|
$
|
460,489
|
|
|
$
|
60,480
|
|
|
$
|
106,292
|
|
|
Weighted-average yield rate
|
0.88
|
%
|
|
1.07
|
%
|
|
1.31
|
%
|
|
1.29
|
%
|
|
1.50
|
%
|
|
1.64
|
%
|
||||||
|
Item 1.
|
Legal Proceedings
|
|
•
|
general economic, industry or political conditions in the U.S. or internationally;
|
|
•
|
changes in demand or market acceptance of our products and products of our customers, and market fluctuations in the industries into which such products are sold;
|
|
•
|
changes in utilization of our manufacturing capacity and fluctuations in manufacturing yields;
|
|
•
|
changes or fluctuations in customer order patterns and seasonality;
|
|
•
|
our ability to secure sufficient wafer foundry, assembly and testing capacity;
|
|
•
|
our ability to ramp our factory capacity to meet customer demand;
|
|
•
|
the mix of inventory we hold and our ability to satisfy orders from our inventory;
|
|
•
|
levels of inventories held by our customers;
|
|
•
|
risk of excess and obsolete inventories;
|
|
•
|
our ability to realize the expected benefits of our acquisitions;
|
|
•
|
changes in tax regulations and policies in the U.S. and other countries in which we do business;
|
|
•
|
competitive developments including pricing pressures;
|
|
•
|
unauthorized copying of our products resulting in pricing pressure and loss of sales;
|
|
•
|
availability of raw materials and equipment;
|
|
•
|
our ability to successfully transition products to more advanced process technologies to reduce manufacturing costs;
|
|
•
|
the level of orders that are received and can be shipped in a quarter;
|
|
•
|
the level of sell-through of our products through distribution;
|
|
•
|
fluctuations in our mix of product sales;
|
|
•
|
announcements of significant acquisitions by us or our competitors;
|
|
•
|
disruptions in our business or our customers' businesses due to terrorist activity, armed conflict, war, worldwide oil prices and supply, public health concerns, natural disasters or disruptions in the transportation system;
|
|
•
|
constrained availability from other electronic suppliers impacting our customers' ability to ship their products, which in turn may adversely impact our sales to those customers;
|
|
•
|
costs and outcomes of any current or future tax audits or any litigation involving intellectual property, customers or other issues;
|
|
•
|
fluctuations in commodity prices; and
|
|
•
|
property damage or other losses, whether or not covered by insurance.
|
|
•
|
the quality, performance, reliability, features, ease of use, pricing and diversity of our products;
|
|
•
|
our success in designing and manufacturing new products including those implementing new technologies;
|
|
•
|
the rate at which customers incorporate our products into their own applications and the success of such applications;
|
|
•
|
the rate at which the markets that we serve redesign and change their own products;
|
|
•
|
changes in demand in the markets that we serve and the overall rate of growth or contraction of such markets, including but not limited to the automotive, personal computing and consumer electronics markets;
|
|
•
|
product introductions by our competitors;
|
|
•
|
the number, nature and success of our competitors in a given market;
|
|
•
|
our ability to obtain adequate foundry and assembly and test capacity and supplies of raw materials and other supplies at acceptable prices;
|
|
•
|
our ability to protect our products and processes by effective utilization of intellectual property rights;
|
|
•
|
our ability to remain price competitive against companies that have copied our proprietary product lines, especially in countries where intellectual property rights protection is difficult to achieve and maintain;
|
|
•
|
our ability to address the needs of our customers; and
|
|
•
|
general market and economic conditions.
|
|
•
|
proper new product selection;
|
|
•
|
timely completion and introduction of new product designs;
|
|
•
|
procurement of licenses for intellectual property rights from third parties under commercially reasonable terms;
|
|
•
|
timely filing and protection of intellectual property rights for new product designs;
|
|
•
|
availability of development and support tools and collateral literature that make complex new products easy for engineers to understand and use; and
|
|
•
|
market acceptance of our customers' end products.
|
|
•
|
proper identification of licensee requirements;
|
|
•
|
timely development and introduction of new or enhanced technology;
|
|
•
|
our ability to protect our intellectual property rights for our licensed technology;
|
|
•
|
our ability to limit our liability and indemnification obligations to licensees;
|
|
•
|
availability of sufficient development and support services to assist licensees in their design and manufacture of products integrating our technology;
|
|
•
|
availability of foundry licensees with sufficient capacity to support OEM production; and
|
|
•
|
market acceptance of our customers' end products.
|
|
•
|
costs related to writing off the value of our inventory of nonconforming products;
|
|
•
|
recalling nonconforming products;
|
|
•
|
providing support services, product replacements, or modifications to products and the defense of such claims;
|
|
•
|
diversion of resources from other projects;
|
|
•
|
lost revenue or a delay in the recognition of revenue due to cancellation of orders and unpaid receivables;
|
|
•
|
customer imposed fines or penalties for failure to meet contractual requirements; and
|
|
•
|
a requirement to pay damages.
|
|
•
|
political, social and economic instability;
|
|
•
|
economic uncertainty in the worldwide markets served by us;
|
|
•
|
trade restrictions and changes in tariffs;
|
|
•
|
import and export license requirements and restrictions;
|
|
•
|
changes in rules and laws related to taxes, environmental, health and safety, technical standards and consumer protection in various jurisdictions;
|
|
•
|
currency fluctuations and foreign exchange regulations;
|
|
•
|
difficulties in staffing and managing international operations;
|
|
•
|
employment regulations;
|
|
•
|
disruptions in international transport or delivery;
|
|
•
|
public health conditions;
|
|
•
|
difficulties in collecting receivables and longer payment cycles; and
|
|
•
|
potentially adverse tax consequences.
|
|
•
|
quarterly variations in our operating results or the operating results of other technology companies;
|
|
•
|
general conditions in the semiconductor industry;
|
|
•
|
global economic and financial conditions;
|
|
•
|
changes in our financial guidance or our failure to meet such guidance;
|
|
•
|
changes in analysts' estimates of our financial performance or buy/sell recommendations;
|
|
•
|
any acquisitions we pursue or complete; and
|
|
•
|
actual or anticipated announcements of technical innovations or new products by us or our competitors.
|
|
Item 6.
|
Exhibits
|
|
|
|
|
31.1
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
31.2
|
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
32
|
Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
101.INS
|
XBRL Instance Document
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
MICROCHIP TECHNOLOGY INCORPORATED
|
|
|
|
|
|
|
Date:
|
|
August 6, 2015
|
By:
/s/ J. Eric Bjornholt
|
|
|
|
|
J. Eric Bjornholt
|
|
|
|
|
Vice President and Chief Financial Officer
|
|
|
|
|
(Duly Authorized Officer, and
|
|
|
|
|
Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|